Benzbromarone as a Long-Term Uricosuric Agent-Reference-Cited by-同舟云学术

Benzbromarone as a Long-Term Uricosuric Agent

Published:1980 Issue: Volume: Page:283-286
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Bluestone Rodney,Klinenberg James,Lee Ian K.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-9140-5_46

Reference12 articles.

1. Zollner N, Dofel W, Grobner W: The effect of benzbromarone on urinary uric acid excretion in normal adults. Klin Wochensehr 48, 426–432, 1970

2. Mertz DP, Sulzberger I, Klopfer M: Diabetes mellitus, hyperlipidemia, fatty liver, hypertension with primary gout and the effect of benzbromarone. Munch Med Wochenschr 112, 241–247, 1970

3. Kotzaurek R, Hueber EF: Clinical experience with 2-ethyl-3 (4-hydroxy-3,5-dibrombenzol-benzofuran (benzbromarone) in the treatment of gout and hyperuricemia. Wien Klin Wochenschr 118, 1014–1018 (No 23), 1968

4. VanBogaert P: Clinical trial of L2214 in the treatment of gout or rheumatological syndromes associated with hyperuricemia. Belg Rheum Med Phys 24, 295–315, 1969

5. Masbernard A, Guilbaud J, Droniou J: Clinical experience in long-term treatment of primary gout with benzofuranne iodine and brome-derivatives. Soc Med Chir Hop 3, 393–410, 1971

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study;Frontiers in Medicine;2021-01-12

2. Benzbromarone in the treatment of gout;Advances in Rheumatology;2019-08-07

3. Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout;British Journal of Clinical Pharmacology;2017-10-10

4. Urate-Lowering Therapy;Kelley and Firestein's Textbook of Rheumatology;2017

5. Uricosuric medications for chronic gout;Cochrane Database of Systematic Reviews;2014-11-14